• Investing
  • Stock
  • Editor’s Pick
  • Economy
The Significant Deals
Stock

MedTech sector outlook for 2025: RBC

by December 21, 2024
written by December 21, 2024

Investing.com — RBC Capital Markets is feeling bullish about the MedTech sector heading into 2025, noting a robust environment driven by innovation, favorable demographics, and a pro-business policy landscape under the Trump administration.

The firm highlights significant opportunities across its coverage universe, from large-cap leaders to emerging mid-cap innovators.

According to RBC, 2025 will be a “catalyst-rich” year for the sector. Large-cap names like Intuitive Surgical Inc (NASDAQ:ISRG) and Boston Scientific Corp (NYSE:BSX) are poised to deliver a standout performance.

ISRG remains a top pick, with its anticipated mid-year launch of the da Vinci (EPA:SGEF) 5 system representing “a major potential catalyst,” according to RBC analysts.

The company’s leadership in surgical robotics, a high-margin and underpenetrated market, positions it for double-digit revenue and earnings per share (EPS) growth.

Similarly, BSX remains uniquely positioned in the cardiovascular and electrophysiology markets, with strong catalysts expected to unfold, including advancements in pulsed field ablation (PFA) and Watchman devices.

“We see BSX as a premier large-cap company poised to deliver double-digit sales and EPS growth in 2025 that is top-tier in MedTech,” analysts led by Shagun Singh said.

In addition to these industry leaders, analysts also point to opportunities in dislocated large-cap names like DexCom Inc (NASDAQ:DXCM), Medtronic PLC (NYSE:MDT), and Edwards Lifesciences Corp (NYSE:EW).

DXCM, described as “the most dislocated name” in RBC’s large-cap coverage, is poised for a turnaround, driven by innovations such as the 15-day G7 sensor.

Meanwhile, MDT offers compelling relative value as it navigates a business turnaround, with renal denervation (RDN) emerging as a key catalyst.

EW, following a reset in investor expectations, is expected to capitalize on growth in transcatheter valve therapies (TAVR) and new interventional categories.

In the mid-cap space, RBC highlights Inspire Medical Systems Inc (NYSE:INSP) and Globus Medical (NYSE:GMED) as standout names.

INSP is leveraging its first-mover advantage in the obstructive sleep apnea market, with next-generation devices and increasing adoption driving significant upside potential.

GMED, known for its strong execution, is positioned for growth as it integrates Nuvasive and continues to innovate in orthopedic and neurosurgical robotics.

“GMED is a top SMID-cap pick for 2025 as return to historical growth/margin profile aided by best-in-class execution appears poised to drive upside,” analysts said.

Speaking more broadly, RBC notes that sector-wide tailwinds, including aging demographics, a shift to more efficient care settings, and the integration of AI and digital solutions, will underpin long-term growth. The firm emphasizes the impact of innovation, particularly in underpenetrated markets such as robotic-assisted surgery, diabetes care, and vascular interventions.

The Trump administration’s policies are seen as broadly favorable for MedTech, with potential corporate tax reductions and a pro-innovation regulatory stance likely to benefit the sector.

Historically, the RBC Large-Cap MedTech Index has outperformed the broader market by an average of 16% during the first year of new presidential terms.

“Overall, we are bullish on the Medical (TASE:PMCN) Supplies & Devices sector in 2025 and like its relative healthcare positioning, and see factors supporting a multi-year runway ahead,” the investment bank concluded.

This post appeared first on investing.com
0 comment
0
FacebookTwitterPinterestEmail

previous post
Retailer Party City files for bankruptcy, will wind down 700 stores
next post
Biden mulls exempting Mexico from imported solar gear tariffs, Bloomberg News reports

You may also like

BASF results down on impairments, restructuring

January 27, 2025

European chipmakers slump as traders gauge DeepSeek AI...

January 27, 2025

Nasdaq futures tumble as China’s AI push rattles...

January 27, 2025

China Vanke’s CEO, chairman resign amid growing liquidity...

January 27, 2025

Fuji Media, rocked by sexual misconduct allegations, says...

January 27, 2025

Italy’s MPS shares fall ahead of Mediobanca board...

January 27, 2025

British Land stock drops following stake sale

January 27, 2025

UMG shares rally after new multi-year pact with...

January 27, 2025

BASF shares indicated 3% lower as impairments drag...

January 27, 2025

Ryanair cuts 2026 traffic forecast amid ongoing Boeing...

January 27, 2025
Fill Out & Get More Relevant News








    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

    Recent Posts

    • Trump implies government could cut contracts and subsidies to Musk’s companies

      June 7, 2025
    • Procter & Gamble to cut 7,000 jobs as part of broader restructuring

      June 6, 2025
    • Shein and Temu see U.S. demand plunge as loophole for cheap goods closes

      June 6, 2025
    • Shein and Temu see U.S. demand plunge as loophole for cheap goods closes

      June 5, 2025

    Categories

    • Economy (245)
    • Editor's Pick (3,646)
    • Investing (505)
    • Stock (6,426)

    Latest News

    • Trump implies government could cut contracts and subsidies to Musk’s companies
    • Procter & Gamble to cut 7,000 jobs as part of broader restructuring

    Popular News

    • Saudi Arabia stocks higher at close of trade; Tadawul All Share up 0.39%
    • DOJ and FTC warn consumers of fraud and price gouging risks ahead of Hurricane Milton

    About The Significant deals

    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 thesignificantdeals.com | All Rights Reserved

    The Significant Deals
    • Investing
    • Stock
    • Editor’s Pick
    • Economy